Professor, University of California, Berkeley. Programs in Optometry, Vision Science, Infectious Disease and Immunity, and Microbiology. Vice President, Tear Film and Ocular Surface Society. Former President, International Society for Contact Lens Research. Councillor, American Society for Microbiology. Recipient of the 2005 Glenn A. Fry Award and the 2010 Korb Award. Editorial Boards: PLoS ONE, Infection & Immunity, and Investigative Ophthalmology & Vision Science.
John and Rebecca Moores Professor of Vision Science, Biology and Optometry
Associate Dean for Graduate Studies and Research in Physiological Optics and Vision Science
Prof. Frishman received her undergraduate degree from Vassar College in Poughkeepsie N.Y. and her MS and PhD in psychology from the University of Pittsburgh. She did postdoctoral training in visual neuroscience at Northwestern University and the University of California San Francisco where she also was a research faculty member. She joined the Optometry faculty in the College of Optometry in 1990, and she has taught in both the professional and graduate programs. Her research has focused on refining noninvasive electrophysiological approaches for evaluating retinal and anterior visual pathway function in normal subjects and subjects with inherited or acquired diseases that affect visual function.
Academic Editor for PLOS ONE and PeerJ, and she was Editor-in-Chief of the journal, Visual Neuroscience (2001-2007), and Documenta Ophthalmologica (2006-2013).
She has served on federal grant review panels, the NIH/NEI National Advisory Eye Council, and she is a fellow of the Association for Research in Vision and Ophthalmology (FARVO), American Academy of Optometry (FAAO) and a board member of the International Society for the Clinical Electrophysiology of Vision (ISCEV).
Research interests include the use of image processing and machine learning techniques for medical image analysis and retrieval, imaging for radiation therapy, survival analysis for cancer, information retrieval, and statistical modeling.
Stephen L. Macknik trained as a postdoc with Zachary Mainen at Cold Spring Harbor Laboratory, and David Hubel at Harvard Medical School. He has a BA in Psychobiology, Biology and Psychology from the Univ of California, Santa Cruz, and a PhD in Neurobiology from Harvard Univ, with Margaret Livingstone. His research seeks to understand the neural underpinnings of visual awareness and attention, and the neural consequences of cerebral blood flow in the healthy brain and in neurological disorders.
Professor of Ophthalmology, Neurology, Physiology at the State University of New York (SUNY) Downstate Medical Center. Founding Member and President of the Neural Correlate Society and Executive Producer of the annual Best Illusion of the Year Contest. Former Executive Board Member of the Association for the Scientific Study of Consciousness. Advisory Board Member and Columnist for Scientific American Mind.
Professor and former Chairperson of Biology and Toxicology at Ashland University in Ohio. My research focuses on the evolution, physiology and biochemistry of alpha crystallins, a group of small heat shock proteins that protect cells against stress and are implicated in numerous diseases such as lens cataracts, Parkinsons, Alzheimers and cancer. My undergraduate research students and I use the zebrafish and other fish species as models to investigate alpha crystallin function. Our work involves qPCR to measure gene expression, CRISPR gene editing, proteomics, transcriptomics, promoter analysis and histology.
My background is in marine biology, systematics, ecology, molecular biology, protein biochemistry and comparative visual physiology. I train undergraduate research assistants in my laboratory and prepare students for graduate and professional schools and work in industry.
Prof Thomas Ritter, leader of research programme, was recruited by the National University of Ireland, Galway as a lecturer in Gene Therapy and Regenerative Medicine and assumed his position in March 2005. Prof. Ritter has over 20 year experience in the field of gene therapy in organ transplantation. He obtained his Ph.D. degree in 1994 from the Max-Planck Research group of Immunology / Rheumatology at the University of Erlangen-Nuremberg, Germany where he worked on the molecular characterization of T cell receptors specific for human collagen type II. Having completed his Post-Doctoral Fellowship at Marseille, Center of Immunology in 1995, Prof. Ritter took up a faculty position at the prestigious Charité University Hospital in Berlin, Germany. He worked as a leader of the gene therapy programme in experimental transplantation in the Institute of Medical Immunology under the directorship of Prof. Dr. H.-D. Volk. His research focused on the development of efficient viral gene-transfer systems for application in transplantation medicine. Prof. Ritter was successful in obtaining funding from the German Research Foundation and the Ministry of Health and Research as well as from industry (Schering). Prof. Ritter completed his 'Habilitation' (postdoctoral lecture qualification) in Immunology in 2002 followed by a promotion to assistant professor in 2003.
Senior staff researcher at the French National Institut of Health Research (Inserm). Head of the therapeutics department and director of the research team "Inflammation, degeneration and vascular remodelling in retinal disease" at the Vision Institute in Paris. Recipient of a ERC starting grant.
Dean Emeritus & University Distinguished Service Professor of Epidemiology & International Health at Johns Hopkins Bloomberg School of Public Health. Awards include the Danone International Prize for Nutrition; the Albert Lasker Clinical Medical Research Award; the Warren Alpert Foundation Prize, & the Duke Elder International Gold Medal. Past President of the Association of Schools of Public, the 19th Chair of the Academia Ophthalmologica Internationalis, & the Chairman of the Lasker Foundation